Approximately 7 Percent of U.S. Population Uninsured in 2023
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, June 18, 2024 -- In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.
Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the 2023 National Health Interview Survey to present health insurance coverage estimates, along with trends from 2019 through 2023.
The researchers found that 25.0 million people of all ages (7.6 percent) were uninsured at the time of the interview in 2023. This number was lower, but not significantly so, than the number seen in 2022 (27.6 million people [8.4 percent]). Among adults ages 18 to 64 years, 10.9 percent were uninsured at the time of the interview in 2023, while 23.0 and 68.1 percent had public and private health insurance coverage, respectively. Among children aged 0 to 17 years, 3.9, 44.2, and 54.0 percent were uninsured, had public coverage, and had private health insurance coverage, respectively.
In 2023, 4.8 percent of those younger than 65 years had exchange-based coverage, with higher coverage seen among males than females (5.1 versus 4.4 percent). From 2019 to 2023, there was an increase seen in the percentage of people younger than 65 years with exchange-based coverage, from 3.7 to 4.8 percent.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-19 07:15
Read more
- When Is It OK to Undergo Routine Surgery After a Heart Attack?
- Two-Fifths of Americans Say They Experience the 'Winter Blues'
- Election Fears Are Keeping Americans Awake at Night, Survey Shows
- Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
- Depression Rates on the Rise for Sexual, Gender Minority College Students
- Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions